News

WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
MedPage Today3h
Investigational Once-Weekly ART Combo Maintained Viral Suppression in HIV
An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...
WHO recommends Gilead's twice-yearly injection for HIV prevention
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
Crain's New York Business1h
Gilead reaches $202M settlement over kickback scheme to promote HIV drug
Pharma giant Gilead Sciences agreed to pay hundreds of millions of dollars to state health insurance programs after admitting ...
The Root40m
What The Hell! Scary Reasons For The Rise In HIV Amongst Black Women…Again
Black women make up just 13% of the U.S. female population, yet they account for over 50% of new HIV diagnoses among women, according to the Kaiser Family Foundation (KFF). That means more than half ...
The Atlanta Voice1h
Peer support groups bridge critical gaps in HIV care
Freda Jones, founder of LOTUS, empowers women living with HIV in Atlanta through a peer-led support group. Peer support is ...
New Study Shows How Providers Can Use Apretude To Prevent And Treat HIV In Black Women
A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...
HIV prevention drug Lenacapavir recommended by WHO
Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...
Loss of $4M grant threatens HIV prevention efforts in Tennessee
This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across ...
STAT23h
ViiV expands licensing deal for its HIV drug in low-income countries
ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...